Skip to content

1) FMT will be started soon after meeting inclusion criteria. 2) Patient who dose not show sufficient response without severe (grade 3 or higher) adverse events can be offered another course of FMT b

2 trials

Sponsors

Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Hamanomachi hospital

Conditions

Steroid refractory/dependent acute graft-versus-host disease of gut after allogeneic hematopoietic stem cell transplantation or donor lymphocyte infusionSteroid resistant/dependent acute graft-versus-host disease of gut after allogeneic hametopoietic stem cell transplantation or donor lymphocyte infusion